News

Prior to joining Bristol-Myers Squibb, Dr Feldman served as professor and head of the division of neurology at University of British Columbia and Vancouver Coastal Health, Vancouver, Canada.

Applications similar to these patents are pending worldwide, and several additional applications that address other compositions and uses have been filed in the US and other territories. These

In July of 2008, Osiris announced the sale of the Osteocel business to NuVasive for an initial payment of $35 million, followed by up to $50 million in

Dr Barer currently serves as chairman and CEO of Celgene. Dr Barer has received a PhD in organic chemistry from Rutgers University. Separately, Amicus announced that Gregory Weinhoff

The lawsuit was filed in response to Amerigroup’s purported termination of its previously disclosed agreement to purchase certain assets of Centene’s New Jersey subsidiary, University Health Plans. Centene

The international distribution agreement was originally entered into in January 2008 with the intention that Q-Med would eventually be responsible for the marketing, advertising, promotion, sale and distribution

According to the company, treatment with SCY-635 was well tolerated and produced a clinically relevant reduction in plasma hepatitis C virus (HCV) RNA. The clinical study was conducted

The sites are University of California Medical Center San Diego, California and Holy Cross Hospital, Fort Lauderdale, Florida. Mercy Hospital Fairfield, Ohio and The Christ Hospital in Cincinnati,

Icon has previously acquired a 70% stake in Beacon Bioscience. Beacon Bioscience was renamed Icon Medical Imaging in 2007. Peter Gray, CEO of Icon, said: “Medical imaging is